RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Paul Wang to Gadolinium

This is a "connection" page, showing publications Paul Wang has written about Gadolinium.
Connection Strength

0.388
  1. Meng J, Xing J, Wang Y, Lu J, Zhao Y, Gao X, Wang PC, Jia L, Liang X. Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis. Nanoscale. 2011 Nov; 3(11):4713-9.
    View in: PubMed
    Score: 0.104
  2. Meng H, Xing G, Blanco E, Song Y, Zhao L, Sun B, Li X, Wang PC, Korotcov A, Li W, Liang XJ, Chen C, Yuan H, Zhao F, Chen Z, Sun T, Chai Z, Ferrari M, Zhao Y. Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells. Nanomedicine. 2012 Feb; 8(2):136-46.
    View in: PubMed
    Score: 0.103
  3. Meng J, Wang DL, Wang PC, Jia L, Chen C, Liang XJ. Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J Nanosci Nanotechnol. 2010 Dec; 10(12):8610-6.
    View in: PubMed
    Score: 0.098
  4. Yin JJ, Lao F, Meng J, Fu PP, Zhao Y, Xing G, Gao X, Sun B, Wang PC, Chen C, Liang XJ. Inhibition of tumor growth by endohedral metallofullerenol nanoparticles optimized as reactive oxygen species scavenger. Mol Pharmacol. 2008 Oct; 74(4):1132-40.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support